SAT-291 Gonadotropin Releasing Hormone Agonist Therapy Improves Hyperandrogenism in an Adolescent with Type A Insulin Resistance Syndrome

Background: Type A insulin resistance (IR) is a form of severe IR due to heterozygous mutations in the insulin receptor gene. It presents with acanthosis nigricans, IR, and hyperandrogenism in the absence of obesity or lipodystrophy. Treatment aims to decrease androgens and improve insulin sensitivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Paprocki, Emily, Barral, Romina, Burgert, Tania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Pediatric Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552534/
http://dx.doi.org/10.1210/js.2019-SAT-291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552534/
http://dx.doi.org/10.1210/js.2019-SAT-291

Ejemplares similares